Zuccato C - Search Results

1

Brain Regional Identity and Cell Type Specificity Landscape of Human Cortical Organoid Models.

Magni M, Bossi B, Conforti P, Galimberti M, Dezi F, Lischetti T, He X, Barker RA, Zuccato C, Espuny-Camacho I, Cattaneo E. Magni M, et al. Among authors: zuccato c. Int J Mol Sci. 2022 Oct 29;23(21):13159. doi: 10.3390/ijms232113159. Int J Mol Sci. 2022. PMID: 36361956 Free PMC article.

2

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses.

Sipione S, Rigamonti D, Valenza M, Zuccato C, Conti L, Pritchard J, Kooperberg C, Olson JM, Cattaneo E. Sipione S, et al. Among authors: zuccato c. Hum Mol Genet. 2002 Aug 15;11(17):1953-65. doi: 10.1093/hmg/11.17.1953. Hum Mol Genet. 2002. PMID: 12165557

3

Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons.

Goffredo D, Rigamonti D, Tartari M, De Micheli A, Verderio C, Matteoli M, Zuccato C, Cattaneo E. Goffredo D, et al. Among authors: zuccato c. J Biol Chem. 2002 Oct 18;277(42):39594-8. doi: 10.1074/jbc.C200353200. Epub 2002 Aug 27. J Biol Chem. 2002. PMID: 12200414 Free article.

4

The enigma of Huntington's disease.

Cattaneo E, Rigamonti D, Zuccato C. Cattaneo E, et al. Among authors: zuccato c. Sci Am. 2002 Dec;287(6):92-7. doi: 10.1038/scientificamerican1202-92. Sci Am. 2002. PMID: 12469651 No abstract available.

5

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.

Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E. Zuccato C, et al. Nat Genet. 2003 Sep;35(1):76-83. doi: 10.1038/ng1219. Epub 2003 Jul 27. Nat Genet. 2003. PMID: 12881722

6

Shc3 affects human high-grade astrocytomas survival.

Magrassi L, Conti L, Lanterna A, Zuccato C, Marchionni M, Cassini P, Arienta C, Cattaneo E. Magrassi L, et al. Among authors: zuccato c. Oncogene. 2005 Aug 4;24(33):5198-206. doi: 10.1038/sj.onc.1208708. Oncogene. 2005. PMID: 15870690

7

From target identification to drug screening assays for neurodegenerative diseases.

Zuccato C, Tartari M, Goffredo D, Cattaneo E, Rigamonti D. Zuccato C, et al. Pharmacol Res. 2005 Sep;52(3):245-51. doi: 10.1016/j.phrs.2005.03.010. Pharmacol Res. 2005. PMID: 15916902

8

The function of the neuronal proteins Shc and huntingtin in stem cells and neurons: pharmacologic exploitation for human brain diseases.

Zuccato C, Conti L, Reitano E, Tartari M, Cattaneo E. Zuccato C, et al. Ann N Y Acad Sci. 2005 May;1049:39-50. doi: 10.1196/annals.1334.006. Ann N Y Acad Sci. 2005. PMID: 15965106 Review.

9

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery.

Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, Valenza M, Cattaneo E. Zuccato C, et al. Pharmacol Res. 2005 Aug;52(2):133-9. doi: 10.1016/j.phrs.2005.01.001. Pharmacol Res. 2005. PMID: 15967378

10

Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease.

Goffredo D, Rigamonti D, Zuccato C, Tartari M, Valenza M, Cattaneo E. Goffredo D, et al. Among authors: zuccato c. Pharmacol Res. 2005 Aug;52(2):140-50. doi: 10.1016/j.phrs.2005.01.006. Pharmacol Res. 2005. PMID: 15967379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters